Specialty Pharmacy (4.0) 4.0

P-PSC 3-3: Clinical Communication Services

Submited by: Tom Goddard

The Basics

Under this standard, the pharmacy must have documentation of the implementation of written policies to:

  • Handle clinical calls 24/7;
  • Timely respond to clinical communications;
  • Counsel patients on request;
  • Clearly spell out the process of escalating issues to a clinician.

Management Tips

Your P&P and staff training addressing these issues should provide staff members with clear guidance on all elements addressed by the standard. Also, be sure to work with your compliance department to make sure your policies are compliant with state regulations, which sometimes establish their own requirements about support services.

Accreditation Tips

Desktop Review
URAC will want you to submit your policies and procedures describing your consumer and prescriber support services. In addition, submit training materials for staff that address patient/prescriber support services. Finally, submit documentation demonstrating that you make your hours of operation available to consumers and prescribers.
Validation Review
The reviewer will interview your staff. The accreditation guide suggests that this is all that the reviewer will do during the validation review, but the staff should be prepared in case the reviewer(s) select call records from a log you provide during the onsite review or examine complaints selected from your complaint log.

  • Health Plan (7.4) 7.4 / 02.19.2021

    P-OPS 12 - Breach Handling

    This standard outlines the requirements for your organization when a privacy breach is discovered. The process must include:Recording the date your organization knew or should have known of the breach;Notifying the privacy and security official(s);Determining whether a breach actually occurred;Once it's determined that a breach did, in fact, occur, Recording the date of the breach;Mitigating the c...

  • Health Plan (7.4) 7.4 / 02.19.2021

    P-OPS 11 - Oversight of Automated Review of Pharmacy Non-Certifications

    If your organization conducts automated review in connection with drug management, you must have written P&Ps that describe the oversight mechanism for such automated review. That oversight must be conducted by both a senior clinician and a clinical oversight body. That oversight body can be, but need not be, the P&T Committee.The oversight of automated review must be active and well-documented. O...

  • Health Plan (7.4) 7.4 / 02.19.2021

    P-OPS 10 - Economic Formulary Considerations

    In order to assure that cost issues do not supercede clinical issues, this standard prohibits consideration of economic factors of a medication before its safety efficacy, therapeutic appropriateness, and side effects have been established. Once those issues have been considered, it is appropriate to evaluate equivalent alternative medications and therapies in terms of their impact on health costs...